Introduction
Flutamide is an anti-androgen drug which is used in Prostate cancer therapy. Its plasma peak concentration is achieved in 2 hours. 1 A single oral dose of 250 mg and 500 mg flutamide leads to maximum plasma concentration (C max ) of 0.02 µg ml ⁄ and 0.1 µg ml ⁄ respectively. 2 After a drug reaches to systemic circulation it can binds to plasma proteins to form drugprotein complexes. Protein binding of drugs is a reversible and dynamic process with bound and unbound drug in equilibrium. This is very important because only the unbound drug exerts pharmacological activity. In addition, changes in the plasma binding of a drug may significantly influence drug disposition. For example if a drug clearance is limited by protein binding, changes in the binding may alter clearance and also total steadystate drug concentrations. 3 Therefore it seems that protein binding studies are of great importance in clinical and pharmaceutical sciences. On the other hand analyzing the free fraction of the drug in study samples would be the main issue demanding the sensitive analytical methods. 4 The gas chromatographic determination of flutamide in blood was reported in 1988 by Schulz et al for a limited range of concentration (0.02-0.250 µg/ml). 1 In another study by Manjunath et al, HPLC system was equipped with a radioactive detector and a gradient solvent system was used for radioactive flutamide determination with 18.3 minutes retention time. 5 The HPLC analysis of flutamide in plasma were also carried out by Iwanaga et al on an separation module coupled to a dual wavelength absorbance detection system which is designed to provide the highest performance in UV-Visible detection and offers the superior sensitivity required for detection of minor impurities in complex applications. The resulting linearity range in this study was determined to be between 0.027 µg/ml and 27 µg/ml. 6 HPLC analysis of flutamide in blood serum were also reported by Filip et al with linearity range of 12.5 -625 µg/Ml. 7 Although a HPLC/ UV method was amplified by Xu Chang-Jiang which could be employed for analysis of flutamide in blood with a good linearity area of 0.1-20 µg /ml, the method needs a very complex extraction procedure and high cost evaporation step. 8 Milli-Q purification system by Merck, Germany was used. High performance liquid chromatography system, Knauer (Berlin, Germany) equipped with solvent delivery system consisted of an on-line degasser coupled to a quaternary low pressure gradient pump were used as chromatographic equipment.
Preparation of stock solution
Stock solution of flutamide (1600 µg/ml) in methanol was prepared and diluted with potassium dihydrogen phosphate buffer solution with pH 7.4 to obtain concentrations in the range of 0.003-16 µg/ml. Acetanilide was used as internal standard (IS). 0.9 mg /ml of acetanilide in methanol was prepared as IS stock solution and subsequently kept at 4°C. The working solution was prepared by further dilution to get the final concentration of 450 µg/ml.
Flutamide-albumin binding study
Appropriate amount of 20% human serum albumin (HSA) and flutamide solution (pH=7.4) were mixed to obtain the desired concentration of the drug (1-16 µg/ml) and HSA (4%) in 4 ml solution. Then the homogeneous mixtures were incubated in duplicate 30 minutes in a shaker incubator at 50 rpm. All samples were protected from light by wrapping the tubes in foil. After 30 minutes, the duplicate mixtures were transferred to the modified ultrafiltration systems and centrifuged at 4000 rpm for 10 minutes in temperature controlled conditions. Samples were extracted and analyzed by developed HPLC-UV method.
Extraction procedure 1ml of flutamide solution in potassium dihydrogen phosphate buffer with pH 7.4 was placed in micro tubes and spiked with acetanilide (as internal standard, 50 µl, 450 µg/ml in methanol). 400 µl of di-ethyl ether as extraction solvent was added over spiked samples in microtubes, followed by 30 seconds vortex assisted liquid-liquid micro extraction. This extraction process is needed for pre-concentration of trace levels of flutamide in samples. After centrifugation (model 5810R, Eppendorf) at 12000 rpm for 5 minutes, the organic layer was separated and evaporation was performed in a pyrex vacuum and degassing chamber resistant to pressure which was wrapped in aluminum foil to protect flutamide from light. The final residue of evaporated organic layer was dissolved in 100 µl mobile phase. Flutamide recovery in the extraction process was calculated by comparing the peak height of extracted samples without internal standard with those obtained for an equivalent amount in mobile phase directly used for analysis.
Chromatographic condition
Analysis was conducted using a Knauer HPLC system (Berlin, Germany). Analytical column was a reversedphase C 8 column Knauer Eurosphere with 150 mm length, 4.6 mm inner diameter and particle size of 5 µm and a pre-column (Eurospher 100-5C8) at room temperature. Injection volume of 25 μl and flow rate of 1 ml/min was applied. Flutamide detection was performed by UV absorption at 226.4 nm. 29% (v/v) methanol, 38% (v/v) acetonitrile and 33% (v/v) potassium dihydrogen phosphate buffer (50 mM) with orthophosphoric acid adjusted pH of 3.2 was selected as mobile phase.
Validation of developed HPLC method
ICH guidelines concerning linearity, limits of detection and quantification, accuracy, precision, specificity and system suitability tests were used to conform developed HPLC method.
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Specificity
It is assessed by successful utilization of developed analysis approach to calculate drugs amount in their formulations or biological fluid components without any interference with their chromatograms. Therefore the specificity of the presented analysis was confirmed by comparing the chromatograms of samples containing flutamide and acetanilide with those of blank solutions.
Linearity
It relates the response directly to the analyte concentration in the sample within a fixed area. Calibration curves for flutamide were constructed between 0. 0625 and 16 µg/ml. The least-square regression analysis was used to calculate linear regression in order to assess linearity of the calibration curve.
Limits of Detection (LOD) and Quantitation (LOQ)
LOD and LOQ decide about the sensitivity of the method. LOD is the lowest concentration of the analyte detected by the method and LOQ is the minimum concentration of analyte that can be determined with acceptable precision and accuracy. 12 There are three different methods indicated in ICH guidelines. The first method relies on visual evaluation. Second method is based on signal to noise ratio and the third method which was used in this study was based on the SD of the curve .In this method LOD and LOQ were calculated using following equations: LOD = 3.3 SD/S and LOQ = 10 SD/S.
Accuracy and Precision
Accuracy was assessed by the method of standard addition. Four standard concentrations of flutamide were prepared in triplicates. All the samples were spiked with constant amount of IS and then were assayed. %RSD and %recovery of all the concentrations were calculated. Calculation of RSD % for within-day and between-day runs leads to the determination of the precision.
System suitability tests
An essential part of a liquid chromatography technique is system suitability tests. These tests are necessary for verification of effectiveness of chromatography system for the analysis which includes column efficiency (N), selectivity factor, resolution, capacity factor and tailing factor.
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Capacity factor (retention factor)
The capacity factor is descript as Kˈ (A) = (t -t 0 )/ t 0 , t in this equation is the retention time of the substance and t 0 mentions retention time for un-retained compound.
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Retention factor in best situation is 0.5< Kˈ (A) <10.
Selectivity factor
It is the ratio of the capacity factor of two peaks. This parameter represents the ability of an HPLC method to separate two analytes from each other.
Resolution
The quality of separation between adjacent peaks is represented by resolution (R) and is descript as R = 2(t 1 -t 2 )/(w 1 -w 2 ) in this equation, t 1 and t 2 are the retention times and ѡ 1 and ѡ 2 represent the peaks width in the baseline. 15 A complete separation of peaks suggests a value of 1.5 for resolution.
Column efficiency
Column efficiency denotes the stationary phase performance and quality of the column pack. Also it is known as number of theoretical plates which can be defined as N = 5.545[2t R / ω h ] 2 where t R and ω h /2 refer to retention time and half of the width of the peak at its base respectively.
Tailing factor
Ideal chromatographic peaks should have Gaussianshaped but in practice most of them do not show ordinary forms. With increasing peak tailing (asymmetry) the accuracy of quantitation decreases and analysts have problems for optimum calculation of the peak area. For this reason tailing factor according to this equation: T = ω 0.05 /2f is determined, ω 0.05 is the interval between front and back slope of peak at 5% of its height, and f is interval between center line and front slope of peak.
Results and Discussion
Method validation Specificity Figure 1 shows a blank sample chromatogram and the chromatogram of a sample consisting acetanilide (IS) and flutamide. The retention times for acetanilide and flutamide were 1.8 and 2.9 min respectively. The analysis of a sample containing flutamide takes 3 minutes which allows to study a large number of samples rapidly compared to Manjunath et al developed method with retention time of 18.3 minutes. 5 As it is clear blank sample shows no peak on the chromatogram indicating no interference between component of sample matrix, acetanilide and flutamide.
Linearity
Calibration curves were plotted using the standard concentrations of 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, 0.0625 µg/ml of flutamide in potassium dihydrogen phosphate buffer solution with pH 7.4 after performing extraction process in duplicate for each mentioned concentration. For each concentration, the peak height was obtained and then plotted versus related concentration to achieve calibration curve. Results showed linear relationship in the range of 0.0625-16 µg/ml of flutamide on three consecutive days. This linearity range was also obtained by Xu Chang-Jiang et al for flutamide analysis in blood but very complex extraction procedure and high cost evaporation step were the main disadvantages of their work compared to ours. 8 A sample chromatogram for three concentrations is presented in Figure 1 . A Linear regression was used to calculate the determination coefficient (r 2 ), slope and intercept of calibration curves tabulated in Table 1 . Consistent with ICH guidelines, the obtained results indicate that the developed method in this work is very sensitive. 10, 11 It is evident that all RSD (%) values are below the accepted value of ±15%. 
Accuracy and Precision
In the present research, RSD (%) and the amount of recovered flutamide by the developed analysis method were demonstrated as intra-day and inter-day precision and accuracy respectively. The intra-day precision and accuracy ranges were 0.2-1.3% and 90-105% respectively. The precision and accuracy for Inter-day | 253 Advanced Pharmaceutical Bulletin, 2016, 6(2), 251-256 evaluation were 0.2-5.3%, 86.7-98.5% respectively. Precision RSD (%) lower than ±15% is acceptable for studied concentration within and between-day results of the precision and accuracy are exhibited in Table 2 and 3 respectively. The analysis results demonstrated a good within and between-day precision and accuracy. 
LOD and LOQ
In this study the LOD and LOQ values of 0.015 and 0.0625 µg/ml were obtained respectively. This indicates that the minimum detectable concentration of flutamide in this study is lower than LOD value of 0.05 µg/ml which was reported by Xu Chang-Jiang et al. 8 However the LOQ value of 0.027 µg/ml which was observed by Iwanaga et al in their study was lower than ours (0.0625 µg/ml). This might be explained by presence of detector with superior sensitivity than ours. 6 System suitability tests Retention time for un-retained compound of our analysis was 1 min. Calculated Kˈ (A) values were 1.35 and 2.87 for acetanilide and flutamide respectively. The value between 0.5 and 10 for Kˈ (A) shows enough space between un-retained compound and desired peak. Kˈ (A) <1, leads to quick elution of desired peak and not accurate retention value is obtained. Kˈ (A) >20 leads to elution slowly. 1< Kˈ (A) <5 shows preferably value. 17 Therefore, retention factor values in this study are categorized in ideal range. In order to well separation of two substances, selectivity factor will be always greater than one and in our case this value was 2.13. 17 In the present work the calculated values for resolution were 1.8 and 3.22 for acetanilide and flutamide respectively. When resolution value is equal to one, the separation of two peaks is 97.7% complete. The overlap is reduced to 0.2% when resolution value is equal to 1.5. 17 For this reason we were able to obtain chromatograms with acceptable resolution. For the column used in this study the number of theoretical plates of 5610 and 9059 were obtained for flutamide and acetanilide respectively. The sharpness of the peak is an indication of column efficiency. The higher plate number value also indicates that the chromatography column is more efficient 17 for this reason the column used had high efficiency for acetanilide and flutamide analysis. Acetanilide, flutamide tailing factors values of 1.24, 1.07 are in the acceptable range of 0.5 ≤ T ≤ 2, indicating symmetry of chromatographic peaks which leads to more accurate quantitation of flutamide. 17 Considering all the above-mentioned data, the advantages of the developed method over other works is its simplicity, applicability to wide range of concentration, very simple extraction procedure with minimum volume of extractant solvent and low cost for evaporation step.
Flutamide-Albumin Binding study
Accurate concentration of free drug in samples was determined using developed HPLC-UV analysis method. By subtracting free concentration from total concentration, the concentration of HSA-bound drug was obtained. Then the percentage of human serum albuminflutamide binding as a function of flutamide concentration was determined. Table 4 denotes the results. It is evident that the binding increases with increasing flutamide concentration. Normally concentrationdependent protein binding could occur with all protein bound drugs. However this increase is in opposite direction which is normally described in the literature. 4, 18 The presence of a competitive protein binder at lower concentrations, or multiple binding sites with different affinities could explain the observed trend.
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Conclusion
The proposed method for flutamide analysis in bio-fluid consist of two steps, flutamide extraction (preconcentration) and HPLC/UV detection. The method had acceptable extraction recovery value of 100 % for flutamide and comparatively is simple and cost effective. Moreover, minimum amount of extraction solvent is used. Extraction followed by HPLC as a rapid, simple and reliable separation method, using UV detection with a good LOQ and LOD values. System suitability test parameters were in acceptable range according to ICH guidelines which make this method very suitable for kinetic in vitro analysis of flutamide in a wide range of concentration.
